VRDN

Viridian Therapeutics, Inc.DE

Company with tickers: VRDN

Market Cap

$1.85B

Shares Outstanding

103,074,740

CIK

1590750

CUSIP

92790C104

13F Activity (30d)

1 filings 1 filers

Website

Visit website

Investor Relations

Investor relations

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date	Headline
2026-06-26	Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease
2026-05-27	Viridian Therapeutics to Participate in Upcoming June Investor Conferences
2026-05-07	Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million
2026-05-05	Viridian Therapeutics Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Stock and Series B Non-Voting Convertible Preferred Stock
2026-05-05	Viridian Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Progress
2026-05-05	Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑2 Clinical Trial in Chronic Thyroid Eye Disease
2026-03-30	Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑1 Clinical Trial in Active Thyroid Eye Disease
2026-02-26	Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
2026-01-08	Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-01-06	Viridian Therapeutics Prepares for Transformational 2026
2025-12-22	Viridian Therapeutics Announces BLA Acceptance and Priority Review for Veligrotug for the Treatment of Thyroid Eye Disease

Past events

Date	Event	Type
2026-06-09	Goldman Sachs 47th Annual Global Healthcare Conference	Conference
2026-06-03	Jefferies Global Healthcare Conference	Conference
2026-05-05	REVEAL-2 Phase 3 Topline Results	Event
2026-03-30	REVEAL-1 Phase 3 Topline Results	Event
2026-03-09	Leerink Partners Global Healthcare Conference	Conference
2026-03-04	TD Cowen 46th Annual Health Care Conference	Conference
2025-12-04	8th Annual Evercore Healthcare Conference	Conference
2025-11-19	Jefferies Global Healthcare Conference in London	Conference
2025-11-12	Stifel 2025 Healthcare Conference	Conference
2025-06-09	Goldman Sachs Global Healthcare Conference	Conference
2025-06-04	Jefferies Global Healthcare Conference	Conference
2025-05-20	RBC Global Healthcare Conference	Conference
2025-03-12	Leerink Global Healthcare Conference	Conference
2025-03-03	TD Cowen Health Care Conference	Conference
2024-12-16	THRIVE-2 Phase 3 Topline Results	Event
2024-09-09	Thrive Phase 3 Topline Results	Event
2024-05-08	Viridian Therapeutics First Quarter 2024 Earnings Call	Earnings call
2023-12-18	Subcutaneous IGF-1R program selection	Event

Source: https://investors.viridiantherapeutics.com/overview/default.aspx